Research & Innovation, Prevention
Researchers from VCU Massey recently exhibited that the inhibition of glucosylceramide synthase can cause death in cancer. This research was demonstrates a previously unknown role for glucosylceramide synthase in the maintenance of lysosomal function. ...
Research & Innovation, Clinical Care
VCU Massey is the first academic health institution in Virginia to offer hepatic artery infusion pump therapy, an innovative treatment option that delivers chemotherapy directly to tumors in the liver. This therapy is offered to patients whose tumors originated in the colon, rectum or bile duct. ...
Research & Innovation, Community Engagement
Through the Department of Pathology at the VCU School of Medicine, Nina Dashti-Gibson, M.D.-Ph.D. student in VCU’s Medical Scientist Training Program, works in the lab of Chuck Harrell, Ph.D., to search for weaknesses in one of medicine's most stubborn problems: pancreatic cancer....
Research & Innovation
October is Liver Cancer Awareness Month. We spoke with Devanand Sarkar, M.B.B.S., Ph.D., associate director for research training and education, and member of the Cancer Biology research program at VCU Massey about how liver cancer research has evolved over the years. ...
Treatments in clinical trials may be more effective or have fewer side effects than the treatments that are currently available. With more than 200 studies for multiple types of cancers and cancer prevention, Massey supports a wide array of clinical trials.
Massey supports hundreds of top cancer specialists serving the needs of our patients. Massey’s medical team provides a wealth of expertise in cancer diagnosis, treatment, prevention and symptom management.
Massey is proud to partner with OncLive to provide interviews and videos from thought leaders and cutting edge articles and resources on cancer.
